MetLife Investment Management’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.1M | Sell |
398,341
-7,846
| -2% | -$716K | 0.16% | 83 |
|
|
2026
Q1 | $41.7M | Sell |
406,187
-10,542
| -3% | -$1.19M | 0.21% | 64 |
|
|
2025
Q4 | $52.2M | Sell |
416,729
-14,961
| -3% | -$1.91M | 0.25% | 48 |
|
|
2025
Q3 | $57.8M | Buy |
+431,690
| New | +$56.7M | 0.28% | 40 |
|
|
2025
Q2 | – | Sell |
-450,416
| Closed | -$59.7M | – | 2730 |
|
|
2025
Q1 | $59.7M | Sell |
450,416
-8,584
| -2% | -$1.09M | 0.32% | 37 |
|
|
2024
Q4 | $51.9M | Buy |
459,000
+6,752
| +1% | +$780K | 0.28% | 48 |
|
|
2024
Q3 | $51.6M | Sell |
452,248
-11,596
| -2% | -$1.27M | 0.3% | 46 |
|
|
2024
Q2 | $48.2M | Buy |
463,844
+52,930
| +13% | +$5.61M | 0.29% | 49 |
|
|
2024
Q1 | $46.7M | Sell |
410,914
-14,776
| -3% | -$1.69M | 0.31% | 45 |
|
|
2023
Q4 | $46.9M | Sell |
425,690
-8,013
| -2% | -$801K | 0.34% | 41 |
|
|
2023
Q3 | $42M | Sell |
433,703
-12,070
| -3% | -$1.27M | 0.33% | 42 |
|
|
2023
Q2 | $48.6M | Sell |
445,773
-12,650
| -3% | -$1.35M | 0.35% | 41 |
|
|
2023
Q1 | $46.4M | Sell |
458,423
-830
| -0.2% | -$87.6K | 0.33% | 41 |
|
|
2022
Q4 | $50.4M | Sell |
459,253
-9,710
| -2% | -$1.01M | 0.38% | 36 |
|
|
2022
Q3 | $45.4M | Sell |
468,963
-6,817
| -1% | -$727K | 0.38% | 36 |
|
|
2022
Q2 | $51.7M | Sell |
475,780
-39,161
| -8% | -$4.45M | 0.4% | 36 |
|
|
2022
Q1 | $60.9M | Buy |
514,941
+128,717
| +33% | +$16M | 0.39% | 36 |
|
|
2021
Q4 | $54.4M | Sell |
386,224
-8,437
| -2% | -$1.08M | 0.45% | 33 |
|
|
2021
Q3 | $46.6M | Sell |
394,661
-11,517
| -3% | -$1.41M | 0.42% | 34 |
|
|
2021
Q2 | $47.1M | Sell |
406,178
-10,234
| -2% | -$1.19M | 0.41% | 35 |
|
|
2021
Q1 | $49.9M | Sell |
416,412
-8,261
| -2% | -$979K | 0.46% | 29 |
|
|
2020
Q4 | $46.5M | Sell |
424,673
-18,398
| -4% | -$2M | 0.44% | 34 |
|
|
2020
Q3 | $48.2M | Sell |
443,071
-15,665
| -3% | -$1.59M | 0.53% | 31 |
|
|
2020
Q2 | $41.9M | Buy |
458,736
+3,167
| +0.7% | +$286K | 0.48% | 37 |
|
|
2020
Q1 | $35.9M | Sell |
455,569
-13,939
| -3% | -$1.16M | 0.49% | 35 |
|
|
2019
Q4 | $40.8M | Sell |
469,508
-11,465
| -2% | -$960K | 0.43% | 36 |
|
|
2019
Q3 | $40.2M | Sell |
480,973
-5,304
| -1% | -$451K | 0.44% | 36 |
|
|
2019
Q2 | $40.9M | Sell |
486,277
-12,920
| -3% | -$1.02M | 0.44% | 37 |
|
|
2019
Q1 | $39.9M | Sell |
499,197
-3,021
| -0.6% | -$225K | 0.43% | 37 |
|
|
2018
Q4 | $36.3M | Sell |
502,218
-8,063
| -2% | -$567K | 0.44% | 38 |
|
|
2018
Q3 | $37.4M | Sell |
510,281
-5,817
| -1% | -$382K | 0.38% | 45 |
|
|
2018
Q2 | $31.5M | Sell |
516,098
-7,717
| -1% | -$468K | 0.37% | 47 |
|
|
2018
Q1 | $31.4M | Sell |
523,815
-14,741
| -3% | -$888K | 0.37% | 47 |
|
|
2017
Q4 | $30.7M | Buy |
+538,556
| New | +$29.8M | 0.35% | 46 |
|
Other funds holding ABT
MetLife Investment Management's ABT Position: Q2 2026 in Review
MetLife Investment Management reduced its Abbott (ABT) stake by 1.9% in Q2 2026, selling an estimated $716K and leaving 398,341 shares worth $36.1M. The position accounts for 0.16% of the portfolio, ranked #83.
MetLife Investment Management first reported a position in ABT in Q4 2017 and has held it in 34 quarters since. The position peaked at $60.9M in Q1 2022. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- MetLife Investment Management held 398,341 shares of Abbott worth $36.1M as of Q2 2026.
- MetLife Investment Management sold 7,846 Abbott shares in Q2 2026, an estimated $716K.
- Abbott made up 0.16% of MetLife Investment Management's portfolio in Q2 2026, its #83 holding.
- MetLife Investment Management first reported a position in Abbott in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Abbott position peaked at $60.9M in Q1 2022.
- 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.